ArTara Therapeutics

CG Oncology

This biopharmaceutical company develops oncolytic immunotherapies for patients with non-muscle invasive bladder cancer.

Rainier Therapeutics

The company develops targeted antibody therapies for patients with early-stage and metastatic bladder cancer.

enGene

This clinical-stage biotechnology company develops non-viral gene therapies for patients with high-risk, non-muscle invasive bladder cancer and other mucosal tissue diseases.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Arda Therapeutics

This biotechnology company develops targeted cell depletion therapies to treat chronic diseases by identifying and removing specific pathogenic cells in patients.

ARase Therapeutics

This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.